Aktienanalyse zu Auna SA (AUNA)AUNAAuna SA

Auna SA is a Luxembourg-based healthcare company. The Company has a patient- centric model providing prepaid healthcare plans, medical care, and oncology solutions, that promotes integrated healthcare system, healthy lifestyles through prevention, research, and education. It offers a wide-ranging practice and prospects that enables to deliver standard services and the possible patient outcomes. Its network includes nearly 31 healthcare network facilities, consisting of regional network of hospitals, clinics, outpatient, and wellness facilities with a total of 2,308 beds. It is also located in Mexico, Peru, and Colombia. It operates in the Healthcare sector.

Auna SA is currently a hold due to mixed signals in its financial performance and market sentiment. The current price is $5.18, which is below the analyst target of $5, indicating limited upside potential. The RSI is at 41.50, suggesting that the stock is nearing oversold territory, but it has not yet reached a strong buy signal. Furthermore, the company reported a 9% year-over-year revenue growth, but adjusted EBITDA declined by 9%, reflecting margin pressures. The main risk is the recent downgrade by JPMorgan, which highlights concerns over the company's financial outlook, particularly after a disappointing EPS surprise of -40% in the last earnings report.